Cargando…

Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: a systematic review and meta-analysis

BACKGROUND: With limited sample sizes and single-institution designs, how complete response (CR) after neoadjuvant chemotherapy (NAC) influences breast conserving surgery (BCS) and its value in prognosis are not clear. METHODS: A systematic research review was conducted using electronic database. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xuan, Dai, Danian, Chen, Bo, Tang, Hailin, Wei, Weidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706340/ https://www.ncbi.nlm.nih.gov/pubmed/29183336 http://dx.doi.org/10.1186/s12957-017-1273-6

Ejemplares similares

The value of neutrophil-to-lymphocyte ratio for response and prognostic effect of neoadjuvant chemotherapy in solid tumors: A systematic review and meta-analysis
por: Li, Xuan, et al.
Publicado: (2018)

Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer: A Meta-Analysis including 12,993 Patients
por: Li, Xuan, et al.
Publicado: (2018)

Breast-conserving surgery versus mastectomy for treatment of breast cancer after neoadjuvant chemotherapy
por: Song, Yu-Chun, et al.
Publicado: (2023)

Efficacy of PI3K/AKT/mTOR pathway inhibitors for the treatment of advanced solid cancers: A literature-based meta-analysis of 46 randomised control trials
por: Li, Xuan, et al.
Publicado: (2018)

“No Ink on Tumor” in Breast-Conserving Surgery after Neoadjuvant Chemotherapy
por: Atzori, Giulia, et al.
Publicado: (2022)

Oncologic necessity for the complete removal of residual microcalcifications after neoadjuvant chemotherapy for breast cancer
por: Lee, Jeeyeon, et al.
Publicado: (2022)

Is Breast Surgery Necessary for Breast Carcinoma in Complete Remission Following Neoadjuvant Chemotherapy?
por: Richter, Hannah, et al.
Publicado: (2018)

Locally advanced breast cancer treated with neoadjuvant chemotherapy: Is breast-conserving surgery feasible?
por: Alawad, Awad Ali, et al.
Publicado: (2020)

Neoadjuvant Chemotherapy Combined with Breast-Conserving Surgery in the Treatment of Triple-Negative Breast Cancer
por: Zhang, Xiaoyu, et al.
Publicado: (2022)

New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
por: An, Junsha, et al.
Publicado: (2021)

Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer
por: Bhattacharyya, M, et al.
Publicado: (2008)

Ultrasound-assisted carbon nanoparticle labeling of neoadjuvant chemotherapy for breast-conserving surgery in breast cancer
por: Lin, Nan, et al.
Publicado: (2022)

Nomogram for Predicting Breast Conservation after Neoadjuvant Chemotherapy
por: Kim, Min Kyoon, et al.
Publicado: (2015)

How Long is It Safe to Wait for Breast Surgery After Completion of Neoadjuvant Chemotherapy?
por: Ma, Tianyi, et al.
Publicado: (2021)

Pretreatment TG/HDL-C Ratio Is Superior to Triacylglycerol Level as an Independent Prognostic Factor for the Survival of Triple Negative Breast Cancer Patients
por: Dai, Danian, et al.
Publicado: (2016)

Pre-treatment serum alkaline phosphatase and lactate dehydrogenase as prognostic factors in triple negative breast cancer
por: Chen, Bo, et al.
Publicado: (2016)

Comparison of breast-conserving surgery with mastectomy in locally advanced breast cancer after good response to neoadjuvant chemotherapy: A PRISMA-compliant systematic review and meta-analysis
por: Sun, Yixuan, et al.
Publicado: (2017)

Oncological outcomes of visibly complete transurethral resection prior to neoadjuvant chemotherapy for bladder cancer
por: Baird, Bryce, et al.
Publicado: (2023)

Sterilization Rate of the Axilla After Neoadjuvant Chemotherapy: The Scope for Conservative Surgery
por: Noronha, Jarin, et al.
Publicado: (2020)

The oncological outcome and influence of neoadjuvant chemotherapy on the surgery in the resectable and locally advanced oral squamous cell carcinoma
por: Su, Xuan, et al.
Publicado: (2019)

Association of surgical margins with local recurrence in patients undergoing breast-conserving surgery after neoadjuvant chemotherapy
por: Lin, Joseph, et al.
Publicado: (2020)

Machine learning for predicting breast-conserving surgery candidates after neoadjuvant chemotherapy based on DCE-MRI
por: Chen, Zhigeng, et al.
Publicado: (2023)

Does neoadjuvant chemotherapy increase breast conservation in operable breast cancer: an Egyptian experience
por: Abdel-Bary, N, et al.
Publicado: (2009)

Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes
por: Volders, José H., et al.
Publicado: (2017)

Case Report: A 3D-Printed Surgical Guide for Breast-Conserving Surgery After Neoadjuvant Chemotherapy
por: Wu, Zhen-Yu, et al.
Publicado: (2021)

circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression
por: Chen, Bo, et al.
Publicado: (2018)

Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients
por: Dai, Danian, et al.
Publicado: (2016)

PARPBP is a prognostic marker and confers anthracycline resistance to breast cancer
por: Chen, Bo, et al.
Publicado: (2020)

Customised 3D-Printed Surgical Guide for Breast-Conserving Surgery after Neoadjuvant Chemotherapy and Its Clinical Application
por: Luo, Jie, et al.
Publicado: (2023)

Avoiding breast cancer surgery in a select cohort of complete responders to neoadjuvant chemotherapy: The long-term outcomes
por: Apte, Anuradha, et al.
Publicado: (2021)

Oncological safety of nipple-sparing mastectomy after neoadjuvant chemotherapy: a systematic review
por: NISSEN, LEONARDO, et al.
Publicado: (2023)

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma
por: Petrillo, A., et al.
Publicado: (2022)

Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy
por: Wu, Kunpeng, et al.
Publicado: (2014)

Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma
por: Jones, R L, et al.
Publicado: (2006)

Predictors of Pathological Complete Response to Neoadjuvant Chemotherapy in Iranian Breast Cancer Patients
por: Sasanpour, Pegah, et al.
Publicado: (2018)

Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
por: Müller, Carolin, et al.
Publicado: (2021)

Pathological complete response following cisplatin or carboplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: A systematic review and meta-analysis
por: Vidra, Radu, et al.
Publicado: (2022)

Adjuvant locoregional radiation therapy in breast cancer patients with pathologic complete response after neoadjuvant chemotherapy: A systematic review and meta-analysis
por: Nikyar, Normehr, et al.
Publicado: (2022)

Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review
por: Chainitikun, Sudpreeda, et al.
Publicado: (2021)

Impact of the time from the completion of neoadjuvant chemotherapy to surgery on the outcomes of patients with gastric cancer
por: Wu, Chaorui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_37r1esj8odp5ao6un2moti1bed